Sanofi India Limited (BSE: 500674)
Health Care · Pharmaceuticals · IN
Rs2,945.55
-2.84% today · -37.3% 1Y
Sanofi India Limited (BSE: 500674) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $700.94M.
Over the last twelve months the share price has lost 37.3%, trading between 2.92K and 4.90K.
Tweenvest scores Sanofi India Limited across four factors: quality 82/100, value 79/100, growth 1/100, dividend 83/100. Its strongest factor is dividend.
500674 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $700.94M
- Revenue (TTM)
- $190.92M
- P/E
- 20.95
- EPS
- 140.59
- Dividend yield
- 4.18%
- Beta (5Y)
- 0.16
- 52-week high
- Rs4,896.00
- 52-week low
- Rs2,915.70
- Avg volume (3M)
- —
- Shares outstanding
- 23.03M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Shineway Pharmaceutical Group LimitedSEHK: 2877 | $714.72M | HK$7.43 | +1.16% |
| Nxera Pharma Co., Ltd.TSE: 4565 | $710.97M | ¥1,232.00 | +0.98% |
| Bliss GVS Pharma LimitedBSE: 506197 | $708.15M | Rs644.55 | -5.80% |
| Supriya Lifescience LimitedNSEI: SUPRIYA | $704.91M | Rs847.65 | -8.95% |
| Hunan Fangsheng Pharmaceutical Co., Ltd.SHSE: 603998 | $696.83M | CN¥10.63 | +2.61% |
| Jiangsu Lianhuan Pharmaceutical Co., Ltd.SHSE: 600513 | $693.81M | CN¥16.28 | +7.89% |
| Genomma Lab Internacional, S.A.B. de C.V.BMV: LAB B | $691.79M | MX$13.04 | +1.95% |
| Hunan Hansen Pharmaceutical Co., Ltd.SZSE: 002412 | $689.65M | CN¥9.18 | +1.21% |
Figures last refreshed Oct 11, 2026.